Daebong Life Science Overview
- Year Founded
-
1986
- Status
-
Public
- Employees
-
136
- Stock Symbol
-
078140
- Investments
-
2
- Share Price
-
$4.84
- (As of Friday Closing)
Daebong Life Science General Information
Description
Daebongls Co Ltd is a South Korea-based company that engages in the manufacturing and selling of raw pharmaceutical products, cosmetic materials, and food additive raw materials with cost and quality competitiveness based on the core technologies related to amino acid manufacturing. Its main products include respiratory treatment drugs, high blood pressure treatment drugs, and digestive treatment drugs. The group also manufactures and sells functional cosmetic materials using fusion synthesis, including Jeju natural materials.
Contact Information
Website
www.daebongls.co.krCorporate Office
- 101, Songdomirae-ro
- Yeonsu-gu
- Incheon, 21989
- South Korea
Corporate Office
- 101, Songdomirae-ro
- Yeonsu-gu
- Incheon, 21989
- South Korea
Daebong Life Science Stock Performance
As of 13-Nov-2026, Daebong Life Science’s stock price is $4.84. Its current market cap is $53M with 10.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.84 | $4.89 | $4.41 - $8.91 | $53M | 10.9M | 18.7K | $0.09 |
Daebong Life Science Financials Summary
As of 30-Jun-2026, Daebong Life Science has a trailing 12-month revenue of $77.4M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 82,054 | 118,458 | 98,134 | 64,961 |
| Revenue | 77,441 | 71,717 | 68,859 | 67,018 |
| EBITDA | 6,614 | 12,393 | 6,772 | 3,645 |
| Net Income | 937 | 7,068 | 5,379 | 3,199 |
| Total Assets | 179,804 | 183,999 | 162,062 | 151,256 |
| Total Debt | 53,556 | 51,017 | 33,679 | 23,710 |
Daebong Life Science Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Daebong Life Science Patents
Daebong Life Science Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026177486-A1 | Oil-in-water type cosmetic composition embedded with visible oil particles carrying skin-beneficial ingredient | Pending | 18-Feb-2025 | ||
| WO-2026155586-A1 | Method for mass production of plant-derived extracellular vesicles, and cosmetic composition thereof | Pending | 20-Jan-2025 | ||
| WO-2026141808-A1 | Cosmetic composition containing perilla frutescens extract | Pending | 26-Dec-2024 | ||
| WO-2026095518-A1 | Pseudo-ceramide complex derived from citron-seed oil, and cosmetic composition comprising same for moisturizing skin and enhancing skin barrier | Pending | 28-Oct-2024 | ||
| WO-2026084340-A1 | Composition comprising tes trioleate and oleamide serinol as active ingredients for alleviating and preventing cellular senescence | Pending | 18-Oct-2024 |
Daebong Life Science Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Daebong Life Science Investments (2)
Daebong Life Science’s most recent deal was a Later Stage VC with Plcoskin for . The deal was made on 15-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Plcoskin | 15-Dec-2025 | Later Stage VC | Surgical Devices | ||
| Incheon Free Economic Zone (9,633.4 Square Meters of Land in Incheon, South Korea) | 21-Jan-2020 | Corporate Asset Purchase | Buildings and Property |
Daebong Life Science ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Chemicals
Industry
Rank
Percentile
Commodity Chemicals
Subindustry
Rank
Percentile
Daebong Life Science FAQs
-
When was Daebong Life Science founded?
Daebong Life Science was founded in 1986.
-
Where is Daebong Life Science headquartered?
Daebong Life Science is headquartered in Incheon, South Korea.
-
What is the size of Daebong Life Science?
Daebong Life Science has 136 total employees.
-
What industry is Daebong Life Science in?
Daebong Life Science’s primary industry is Distributors/Wholesale.
-
Is Daebong Life Science a private or public company?
Daebong Life Science is a Public company.
-
What is Daebong Life Science’s stock symbol?
The ticker symbol for Daebong Life Science is 078140.
-
What is the current stock price of Daebong Life Science?
As of 13-Nov-2026 the stock price of Daebong Life Science is $4.84.
-
What is the current market cap of Daebong Life Science?
The current market capitalization of Daebong Life Science is $53M.
-
What is Daebong Life Science’s current revenue?
The trailing twelve month revenue for Daebong Life Science is $77.4M.
-
What is Daebong Life Science’s annual earnings per share (EPS)?
Daebong Life Science’s EPS for 12 months was $0.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
